Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LymphoSign
Limoges, Nouvelle-Aquitaine, France
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
LymphoSign is a French biotechnology company specializing in the molecular diagnosis and classification of lymphomas. The company has developed the LymphoSign test, a genomic tool that utilizes high-throughput RNA sequencing and proprietary bioinformatics to characterize the signature of B-cell lymphomas. This technology enables clinicians to precisely subtype tumors, facilitating more accurate diagnoses and personalized treatment plans for patients. As a spin-off from the University of Limoges and the Limoges University Hospital, LymphoSign bridges the gap between academic research and clinical oncology practice.
- Therapeutic areas
- Oncology
- Modalities
- Molecular diagnosticsNext-generation sequencing
- Industry
- Molecular Diagnostics
02
Partnerships
University of LimogesLimoges University HospitalCALYM Carnot Institute
Beyond the preview
Go deeper on LymphoSign.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LymphoSign.